I. INTRODUCTION
Cancer is a complex disease and the apparent impenetrability of the disease is largely due to multiple, often redundant, pathways that appear to evolve through the genetic instability of cancer cells. Molecular imaging is a term broadly used to describe imaging applications that detect molecules or molecular signals. It encompasses gene expression imaging as well as vascular and metabolic imaging. In recent years, there has been a tremendous surge of interest in the application of magnetic resonance (MR) molecular imaging techniques in cancer research as well as in the clinical management of the disease. The ability to identify and image common key pathways specific to cancer cells and the ability to image the effectiveness and outcome of strategies designed against these targets is critically important for the treatment of this disease. MR methods are particularly T agents are typically paramagnetic and effectively shorten the T (longitudinal) relaxation time to produce signal hyperintensity in T -weighted images. These agents are mostly chelates of the lanthanide gadolinium (Gd). T relaxivity values of Gd-based CAs are usually in the range of 5-20 (mM s) [1] and up to 80 (mM s) for the blood pool CA MS-325 bound to albumin [2] . These agents affect both T and T of tissues, but because the intrinsic T of tissues is much longer than the intrinsic T , the relative change in T exceeds that of T , for an equivalent percentage change. Imaging sequences sensitive to this change are called "T -weighted" sequences. T contrast agents most effectively shorten the T (transverse) relaxation time and produce hypointensity in T -weighted images. These agents are generally polymer-coated iron oxide nanoparticles that shorten T through the susceptibility-induced local magnetic field heterogeneity. Iron-oxide-based superparamagnetic CAs can have T relaxivities reaching 200 (mM s) [3] . Since the intrinsic tissue T is shorter than its intrinsic T , the CA-induced percentage change in tissue T is greater than the percentage change in T , for an equivalent change in absolute relaxation time. Imaging sequences that are sensitive to this change are called "T -weighted" sequences. In addition to T relaxation, the transverse magnetization is also affected by inhomogeneity in the static magnetic field, which results in enhanced relaxation. The relaxation due to both the T mechanism as well as the magnetic field inhomogeneity is called T relaxation.
T Contrast Agents: Gd III , Mn II , or Fe III chelates are used as T CAs because their paramagnetic moieties shorten the T of the protons of bulk water, generating positive contrast enhancement in a T -weighted image. Gd diethylene triamine penta-acetate (GdDTPA) is the most commonly used CA in this category because of the high stability of the DTPA complex. Multiple chelates of Gd ions can be attached to a single polymer molecule to increase its relaxation efficiency. These multichelate Gd-polymer complexes include high molecular weight and longer half-life agents like albumin-GdDTPA [4] , [5] and other conjugates of multichelate Gd ions with polymer carriers such as poly-L-lysine [6] , [7] , avidin [8] , and polyamidoamine (PAMAM) dendrimers of different generations [9] , [10] . The relaxivity of these larger complexes is generally a linear function of the number of Gd ions per complex.
While protons provide the highest sensitivity of detection, their biological abundance often makes H MR lack molecular specificity. Targeted CAs have therefore been developed to probe specific molecules. For such CAs, the minimum detectable molecular concentration depends on the labeling efficiency of the CA or that of the molecular probe. For instance, cell surface receptors with high expression levels ( 10 per cell) have a concentration of 10 binding sites per ml 1 M . With current MRI detection capability, each receptor must be labeled with more than ten Gd.
In recent studies, large Gd complexes such as paramagnetic polymerized liposomes [11] and Gd-perfluorocarbon nanoparticles [12] , [13] were targeted to integrin receptors using monoclonal antibodies or target peptides that were either attached via biotin-avidin linkers or covalently bound to the nanoparticle. These studies demonstrated the ability of magnetic resonance imaging (MRI) to detect integrin receptors expressed on the angiogenic endothelium. Human folate receptors in ovarian xenografts were imaged with the small folate-conjugated GdDTPA magnetic dendrimer CA [14] . In a study by Gohr-Rosenthal et al. [7] , Poly-L-Lysine-GdDTPA was covalently bound to an anti-mucin mAb to image a mucin-like protein expressed in gastrointestinal carcinomas. More recently, a two-step labeling strategy was used to image the HER-2/neu receptor in vivo [8] . A biotinylated anti-HER-2/neu mAb was used to prelabel the HER-2/neu receptor. A GdDTPA-avidin conjugate was systemically delivered 12 h later. The GdDTPA-avidin conjugate bound to the biotinylated antibody, generating positive contrast in T -weighted images of HER-2/neu expressing tumor xenografts.
As mentioned earlier, a novel approach of using enzyme-specific relaxivity amplification has been developed to image molecular targets using MRI. In one such approach, -galactosidase, was used to mediate the catalytic removal of the sugar cap of a Gd caged CA, thereby exposing numerous water molecules to the inner-sphere relaxation effects of gadolinium and consequently shortening T [15] . In another approach, peroxidase enzymatic amplification was used to image the E-selectin expression on the surface of endothelial cells [16] . With this approach, the enzymatic polymerization of hydroxyphenol-modified Gadoterate meglumine (GdDOTA) monomers resulted in MR hyperintensity through a significant increase in T relaxivity.
T Contrast Agents: Since Gd-based CAs shorten T and T , some Gd-based CAs are also used to generate T contrast. However, most T and T CAs currently in use rely on an iron oxide core to generate contrast. Monocrystalline iron-oxide nanoparticles (MION) and polycrystalline superparamagnetic iron-oxide nanoparticles (SPIO) generate T contrast through the Curie spin effect [17] . These nanoparticles also generate T contrast through the susceptibility-induced local magnetic field inhomogeneities. Iron-oxide nanoparticles not only produce contrast detectable at nanomolar concentrations but also have an increased probability of uptake in the tumor due to their long circulation time.
MION ( 5 nm) and SPIO ( 30 nm) cores are coated with biopolymers such as dextran or other polysaccharides, or unilamellar vesicles, to provide biocompatibility and chemical stability to the CA. Nonspecific cellular uptake of these nanoparticle CAs occurs through phagocytosis and pinocytosis. Nanoparticle-labeled cells with iron concentrations as low as 1. 7 10 g/cell were successfully detected with MRI [18] ; Dodd et al. [19] detected a single T cell labeled with SPIO while Bulte et al. [20] have tracked mangetodendrimer-loaded stem cells both in vivo and in vitro.
The strategy of targeting iron-oxide nanoparticles to selected receptors using mAb has been used to image lymphocytes in culture; a biotinylated anti-lymphocyte-directed mAb was conjugated to a biotinylated dextran-coated SPIO with a streptavidin linker, generating selective negative contrast enhancement of lymphocyte suspensions [21] . Kang et al. [22] have imaged E-selectin expression in human endothelial cells by conjugating a F ab fragment of the anti-human-E-selectin mAb to cross-linked iron oxide (CLIO) nanoparticles. Only cells incubated in the presence of the ILcytokine demonstrated negative contrast on T -weighted images. Similarly, HER-2/neu expression in malignant breast cancer cells was detected with a two-step labeling process where biotinylated Herceptin mAb was conjugated with streptavidin-SPIO nanoparticles [23] . Strong T contrast was detected in AU-565 cells with high levels of HER-2/neu receptor expression, as shown in Fig. 1 .
Receptor targeting with iron-oxide nanoparticles has also been applied in vivo. Since the protein synaptotagmin binds to phosphatidylserine residues that relocate to the outer leaflet of the plasma membrane in apoptotic cells, SPIO particles conjugated to the C2 domain of synaptotagmin have been used to image apoptosis in solid tumors following chemotherapy [24] . Weissleder et al. [25] engineered 9L glioma cells to express a modified transferrin receptor, ETR, with a knocked-out negative feedback regulation domain. MION particles conjugated to human holo-transferrin (a substrate for an engineered human transferrin receptor, ETR) were internalized by these cells in situ and in vivo, generating detectable contrast in T -weighted MR images.
B. MR Spectroscopic Imaging and Water Exchange
Although H MR spectroscopy (MRS) provides the highest sensitivity, suppression of the strong signal from water and mobile lipids is required for in vivo detection of metabolites. The F isotope exhibits approximately 80% of proton receptivity. The complete absence of background signal from natural fluorine makes it a useful reporter for in vivo MR. Stegman et al. [26] used the bacterial or yeast enzyme cytosine deaminase (CD) to convert 5-fluorocytosine (5-FC) to 5-fluorouracil (5-FU) and detected the conversion in vivo, with F MRS. Solid tumors derived from yeast CD transfected cells were easily detected in vivo since the CD enzyme is not mammalian. In a study by Aboagye et al. [27] , CD was covalently conjugated to an mAb specific to the L6 antigen expressing tumors derived from human lung adenocarcinoma H2981 cells. Here too, the signal from 5-FU was detected in these tumors with F MR spectroscopic imaging (MRSI), following administration of 5-FC.
Chemical-exchange saturation transfer (CEST) is a spectroscopic technique that permits MR detection of exchangeable water protons by detecting changes in the bulk water signal. Changes in the bulk water signal intensity are measured with and without RF irradiation at the chemical shift of the exchangeable group [28] - [30] . Magnetization transfer from the exchangeable protons to numerous bulk water protons can provide a sensitivity enhancement factor of over 5000 for specially optimized probes such as polyuridilic acid (imino protons [31] ). This proton transfer enhancement factor (PTE) is defined as
where S and S are the water signal intensities with and without RF irradiation, respectively. CEST efficiency is determined by the exchange rate constant and the number of exchangeable protons. For meaningful MR detection, the proton exchange between bulk water and the exchangeable group of the CA should be fast enough to allow multiple water molecules to exchange with the exchangeable group in the CA but slow enough to allow sufficient spectral separation [30] . A large chemical shift between bulk water and the exchangeable group enables the use of higher exchange rates with a correspondingly higher PTE and can be attained with paramagnetic shift reagents [32] , [33] . CEST agents provide sensitivity comparable to paramagnetic CAs (for an equivalent number of exchangeable groups and Gd-chelates), suggesting that dedicated CEST "contrast agents" may be used as probes for targeted MRI. Although the MR imaging probes and methods discussed above can be successfully used to image molecular targets in isolated cells, their application in vivo is challenging. The translation of these techniques into the clinic will require a substantial improvement in both CA chemistry and MR imaging technology.
III. MR IMAGING OF TUMOR VASCULATURE
Both the metabolism and the physiological microenvironment of solid tumors are dependent on the tumor vasculature. The vascular network provides cancer cells with nutrients to grow, avenues for dissemination, and a means through which anticancer agents may be delivered. Tumor growth, metastasis, and therapy are therefore strongly dependent on the vasculature. Numerous studies spanning more than a century (see [34] and [35] for review) have identified several characteristic features of tumor vasculature. These include spatial heterogeneity and tortuous architecture, arterio-venous shunts, acutely and transiently collapsing vessels, angiogenic sprouting with poorly differentiated fragile and leaky vessels lacking in smooth muscle cell lining, and vasculature that is frequently unable to match the rapid growth of cancer cells resulting in areas of hypoxia and necrosis [36] .
Based on the type of CA and the imaging sequence, MR methods can be used to derive different parameters that characterize the tumor vasculature (see Table 1 ). These methods mostly rely on the use of exogenous CAs, although as discussed, endogenous contrast mechanisms can also be used to characterize tumor vasculature. The three parameters typically derived from these MR methods are relative blood flow, vascular volume, and vessel permeability. For vessel permeability, usually an effective "permeability-surface area" product (PS), also referred to as "capillary-diffusion capacity" in the case of microvessels, is obtained by determining the rate of extravasation of an intravascular probe from the vessel into the tumor interstitium. PS values obtained by this technique depend on factors such as the molecular weight, size, and charge of the probe.
A. Extrinsic or Exogenous Contrast
As mentioned earlier, tissues that take up Gd-based CAs are brightened in T -weighted images. T and T shortening from the susceptibility-induced effects of these Gd-based tracers can also be used to characterize tumor vasculature; tissues that take up the paramagnetic agent are darkened in T -and T -weighted images. Tissue vascular parameters are calculated from tracer kinetics based on the tissue concentration of the CA and the induced relaxivity changes.
Low Molecular Weight Contrast Agents: Low molecular Gd-based CA such as Gadoteridol, Gd-HP-DO3A (Prohance), Gadopentate dimeglumine, Gd-DTPA (Magnevist), Gadoversetamide (Optimark), and Gadodiamide, Gd-DTPA-BMA (Omniscan) are the only class of paramagnetic agents in routine clinical use [37] - [39] . T relaxivity changes induced by the CA are analyzed for influx and efflux transfer constants and for determining the extravascular, extracellular volume fraction [40] . These CAs are not freely diffusible and do not enter cells. The standard kinetic parameters that can be derived from dynamic contrast-enhanced T -weighted MRI are min , the volume transfer constant between the blood plasma and the extravascular extracellular space (EES), min , the rate constant between the EES and blood plasma, and (%), the volume of the EES per unit volume of tissue, i.e., the volume fraction of the EES [41] . These three parameters are related by (2) where is dependent upon the tissue blood flow and PS (Fig. 2) . Tofts et al. [41] have summarized four special cases of the two-compartment model, wherein one can extract PS and flow information based on certain assumptions, as shown in Table 1 . The utility of these parameters in detecting tumor angiogenesis as well as in evaluating the efficiency of antiangiogenic therapy has also been studied [42] - [45] .
At high enough doses of the CA, differences in the magnetic susceptibility of the intra-and extra-vascular space result in microscopic magnetic field inhomogeneities. Line-broadening effects dominate the MR contrast through diffusion and magnetic field inhomogeneity-induced signal dephasing, leading to contrast in T -weighted images. Spin echo (SE) and gradient echo (GE) sequences have differential sensitivity to vessel caliber [46] , [47] . For a given CA dose and echo time, the ratio of the change in the GE relaxation rate T to the change in the SE relaxation rate T is directly proportional to the vessel radius [46] , [47] . Dennie et al. [48] have demonstrated the application of this approach for assessing tumor angiogenesis in a brain tumor model.
Relative cerebral blood volume (rCBV) maps can be derived from first-pass dynamic susceptibility contrast (DSC) studies with good spatio-temporal resolution [42] , [49] . Preliminary studies with this approach suggest that MRI-derived rCBV can differentiate histologic tumor grade [42] . A potential problem in obtaining rCBV with low molecular weight tracers is that the tracer can leak into the tumor when the blood brain barrier is disrupted, which is often the case in brain tumors, and MR data should be corrected for leakage effects [50] . For example, Donahue et al. [50] have Table 2 observed a positive correlation between GE rCBV corrected for leakage effects and histologic tumor grade.
Most two-compartment models assume that water is in fast exchange between the vascular and EES compartments. This assumption may not apply in some tissues [51] and may lead to errors in the estimate of vascular volume [52] . Errors in the vascular volume estimates due to intermediate or slow exhange can be minimized by applying rapid imaging techniques and models of analyses such as BOLus Enhanced Relaxation Overview (BOLERO) [53] .
High Molecular Weight Contrast Agents: Due to their rapid extravasation, low molecular weight CAs are not ideal for quantifying vessel permeability. High molecular weight CAs such as albumin-GdDTPA compounds [4] and polylysine-GdDTPA [6] can better quantify vascular volume and PS due to their long intravascular half-life. As shown in Figs. 2 and 3 , vascular volume and PS can be spatially mapped from changes in tissue relaxation rates, which are proportional to the tracer concentration, assuming fast intercompartmental water exchange [54] .
The blood concentration of albumin-GdDTPA equilibrates in 2-3 min and remains constant for at least 40 min after an intravenous bolus injection [5] , [55] . A linear model can be employed [56] to derive maps of tumor vascular volume and permeability from quantitative T maps acquired before and at time points after intravenous administration of albumin-GdDTPA (Fig. 3) . Bhujwalla et al. [5] have used this linear model approach to differentiate between the vasculature of metastatic versus nonmetastatic breast and prostate cancer xenografts. The study showed that regions of high vascular volume had low vessel permeability and vice versa. The data suggest that macromolecular therapeutic agents would have poor delivery in viable well-vascularized regions and would leak out in poorly vascularized already dying regions. The study also demonstrated that both vascularization and invasion are required for metastasis to occur. Turetschek et al. [57] used albumin-GdDTPA to measure the transendothelial permeability (i.e., ) and correlate it to histologic tumor grade in a breast tumor model. The study concluded that albumin-GdDTPA more accurately characterized tumor grade than a rapid clearance blood pool CA (P792). The accuracy of this approach depends on the validity of assuming fast water exchange between the intra-and extra-vascular compartments, and it may underestimate vascular volume in the presence of either slow and/or intermediate water exchange [58] , [59] .
B. Intrinsic or Endogenous Contrast
Intrinsic or endogenous contrast can also be exploited to characterize tumor vasculature. For instance, susceptibilityinduced T relaxation of oxygenated versus deoxygenated blood can be used to generate blood oxygen level-dependent (BOLD) contrast. The BOLD technique was originally proposed by Ogawa et al. [60] for brain imaging and subsequently adapted to image tumor microvasculature [61] . The functional dependence of T on blood oxygenation and blood volume fraction is given by (3) where is the fraction of oxygenated blood and is the blood volume fraction. In hypoxic tumors where , the contrast produced by the BOLD effect depends primarily on and permits the rapid in vivo determination of fractional blood volume. Such a susceptibility-based technique has also been used to detect changes in tumor vascularization following induction of angiogenesis by angiogenic cytokines [61] and to obtain "functional vasculature" maps of genetically modified HIF-1 (+/+ and -/-) animal tumor models, showing that the loss of HIF-impaired vascular function and prevented formation of large vessels in embryonic stem cell derived tumors [62] . BOLD contrast provides a fast and truly noninvasive measure of tumor vascularization, since it does not require the injection of a CA. However, one cannot measure vascular permeability or tumor blood flow quantitatively with this approach. Also, susceptibility-based contrast mechanisms such as BOLD are not solely related to the oxygenation status of blood but are also affected by factors such as oxygen saturation, hematocrit, blood flow, blood volume, vessel orientation, and geometry [63] .
Another method to generate endogenous contrast is arterial spin labeling (ASL). With ASL, arterial blood is magnetically tagged proximal to the imaging slice using spatially selective pulses. The tagged blood is then used as a perfusion tracer to quantify blood flow in the downstream tissue. ASL requires high blood flow along with relatively long T relaxation times for the magnetization to be retained until the tagged blood reaches the tissue of interest. Silva et al. [64] used ASL to quantify blood flow in rodent brain tumors. Blood flow was 36.3 18.9 ml/100 g/min in the tumor core and 85.3 26.9 ml/100 g/min in the tumor periphery. These values were significantly lower than blood flow in normal contra-lateral white matter (147.7 31.1 ml/100 g/min).
IV. TUMOR PHYSIOLOGY AND METABOLISM
The poor vascularization of tumors frequently leads to areas of hypoxia, substrate deprivation, build-up of lactate, and extracellular acidosis, which are some of the typical physiological and metabolic characteristics of tumors [36] . Although the tumor vasculature plays a key role in controlling tumor metabolism, cancer cells also display aberrant metabolism such as increased glycolysis and altered choline phospholipid metabolism. MRS and MRSI of nuclei such as H, C, and P can be used to measure pH, energy status, and concentrations of certain metabolites within tumors. These parameters provide important information about tumor malignancy, invasiveness, and response to therapy.
A. H MRS
H MRS provides the highest sensitivity of detection, permitting the acquisition of H MR spectra from localized regions within a tumor. Therefore, the spatial distribution of metabolites within a tumor can be readily obtained with H MRS as shown in Fig. 4(b) . The heterogeneity of the tumor vasculature results in a nonuniform intratumoral distribution of oxygen, pH, and metabolites [36] . H MRSI can characterize the metabolite distribution within a tumor [see Fig. 4(d) ], detect the heterogeneity of metabolic changes, and assess response following therapy [65] , [66] . Unedited proton spectra are dominated by water and mobile lipid signals whose broad resonances can mask signals of other metabolites. Selective suppression techniques can be employed to suppress the water and lipid signals during MRS data acquisition. Water suppression can be achieved using the VAPOR [67] , CHESS [68] , or PRESS sequences [69] . Frequency-selective refocusing can also be utilized to reduce the water signal [70] , [71] .
Although signals from the methyl and methylene protons of mobile lipids can provide useful information [72] - [74] , they obscure signals from resonances such as lactate and alanine. To detect lactate without overlapping lipid signals, coherence-selection through gradient filtering can be used [75] , [76] with spectral editing using adiabatic pulses [77] and additional phase cycling when necessary. Localized presaturation can also be used when the lipid signal is localized to the tumor periphery [70] , [78] . It is possible to suppress both the water and the lipid signals in a single acquisition using homonuclear gradient-coherence transfer in conjunction with a frequency selective pulse [79] , [80] .
Proton spectra of tumors typically exhibit elevated levels of lactate and total choline [81] , [82] . Elevated lactate concentrations are most likely due to a combination of increased glycolytic activity, poor blood flow, and hypoxia. As demonstrated in Fig. 4(a)-(d) , tumor H MR spectra exhibited elevated levels of total choline primarily due to increased cellular phosphocholine (PC) concentrations. Immortalized oncogene-transformed or tumor-derived human mammary epithelial cells, representing different stages of breast carcinogenesis, exhibited a step-wise increase of PC and total choline (tCho: GPC PC Free choline) levels [83] . The PC to GPC ratio increased during malignant transformation in human mammary epithelial cells [83] . An increase in choline transport rate [84] , increased choline kinase expression, and activity [85] , [86] and increased phospholipase A2 [87] , [88] and phospholipase D [89] , [90] activities are some of the mechanisms which contribute to the elevated total choline and PC levels in tumors (reviewed in [91] ). In the clinic, the utility of MRSI of total choline is currently being evaluated for detecting cancer and following its response to therapy in breast [92] , prostate [93] , and brain [94] cancer patients.
B. C MRS
Carbon-13 MRS is useful for studying metabolic fluxes and intermediary metabolism. As shown in Fig. 5 , C-labeled glucose can be used to determine the glycolytic rate of a tumor [95] , [96] and C-labeled choline can be used to follow choline membrane metabolism [97] . C-labeled precursors have been used in high resolution C MR studies of cells or tissue extracts, in noninvasive cell perfusion studies of isolated cells, and in infusion studies of animal tumor models.
C -choline has been used to study choline phospholipid metabolism in breast cancer cells to delineate enzymatic and molecular causes underlying the increased total choline and PC levels [84] , [98] . Katz-Brull et al. [84] observed enhanced choline transport and choline kinase activity in perfused cells using C-labeled choline. Their study also showed that choline phosphorylation rates were higher than choline transport rates, indicating that the increase in PC was not attributable entirely to choline transport.
In poorly differentiated transplanted tumors, C -labeled glucose is metabolized to lactate [95] , [99] - [101] , whereas well-differentiated tumors such as rat hepatoma demonstrated metabolic behavior close to the tissue of origin [102] . Lactate levels in tumors are related to several parameters such as glycolytic rates, blood flow, glucose supply, hypoxia, venous clearance, extent of necrosis, and degree of inflammatory cell infiltration [103] . Terpstra et al. [103] showed that for viable neoplastic cells elevated lactate in tumors correlated well with high glycolytic cell activity. They also observed a putative threshold above which glucose availability and blood flow did not significantly influence lactate levels. Areas of necrosis did not exhibit a strong correlation with levels of intratumoral lactate. In a study by Nielsen et al. [96] using volume localized C MRS with H C cross polarization, a strong correlation was observed between decreasing tumor oxygenation and increasing glycolytic rate in a murine mammary carcinoma model.
Since the C nucleus has a low MR sensitivity, several approaches have been developed to increase the sensitivity of C MRS, and some of these approaches have been applied in humans [104] . The detection sensitivity of C-labeled compounds can be significantly improved up to levels approaching that of the H nucleus by the indirect detection of protons coupled to the nucleus of interest [105] , [106] . Heteronuclear cross-polarization transfer can also be used to increase the sensitivity of direct C MRS [107] .
C. P MRS
Phosphorus-31 MRS can detect metabolites such as nucleoside triphosphates (NTP), phosphocreatine (PCr), inorganic phosphate P , phosphodiesters (PDE), and phosphomonoesters (PME). Although less sensitive than H MRS, P MRS can resolve signals from PME and PDE in vivo. PME concentrations in human breast tumors are significantly increased compared to normal breast tissue [108] . A decrease of the PME signal was detected in breast tumors that responded to the standard course of chemotherapy [108] . Representative P MR spectra from intact perfused MCF-12A human mammary epithelial cells and MDA-MB-231 human breast cancer cells are shown in Fig. 6 . Higher PC concentrations were detected in the malignant MDA-MB-231 cells compared to immortalized, nonmalignant MCF-12A cells.
Energy metabolites such as NTP and PCr detected in tumor P MR spectra depend on parameters such as glucose and oxygen delivery, oxygen consumption rates, cell density, and nutritive blood flow. With tumor progression and the accompanying reduction of blood flow, high-energy metabolite levels such as NTP and PCr decreased, and P indicated by asterisks in the choline structure schematic) for 3 or 27 h. Cells were extracted using a dual-phase extraction method and C MR spectra were obtained from the water-soluble fractions and the lipid fractions at both time points. The 27-h time point shows metabolites derived from a combination of biosynthetic and breakdown pathways. At this time point, the C label was detected in glycerophosphocholine (GPC), phosphocholine (PC), and free choline (Cho) in the water-soluble fraction and in membrane phosphatidylcholine (PtdCho) in the lipid fraction. At the 3-h time point C labeling was incorporated only through the biosynthetic pathways of choline membrane metabolism. Labeling of PtdCho did not occur at this time point; therefore, the contribution of the C label from PtdCho breakdown pathways was not detectable. levels increased [109] , [110] . P MRS studies have also demonstrated that ratios of PCr P and NTP/P were significantly correlated with tumor oxygenation [111] . In a study using four cell lines, Rofstad et al. [112] found that within a cell line, the NTP PCr P ratio decreased with increasing tumor volume and radiobiological hypoxic fraction, which is an important parameter for radiation therapy. There was no correlation between the NTP PCr P ratio and radiobiological hypoxic fraction across cell lines; dissociation between energy metabolism and the radiobiological hypoxic fraction can occur if cells are highly glycolytic and require only small amounts of oxygen. P MRS can also be employed to detect metabolic responses of tumors to changes in blood flow and oxygenation during therapy [113] .
In vivo and in vitro investigations using P MRS have complemented the H MRS studies of choline phospholipid metabolism (reviewed by [81] , [91] , [114] , and [115] ). Ronen et al. [116] detected higher PC levels in mutant ras transfected NIH 3T3 cells compared to their nontransfected counterparts; increased PC in the ras transfected NIH 3T3 cells was associated with Ras activation. Glunde et al. [117] observed an increase of the GPC/PC ratio following treatment of malignant human mammary epithelial cells (HMECs) with the nonsteroidal anti-inflammatory agent indomethacin. The increased GPC/PC ratio suggested that with indomethacin treatment, the choline metabolite profile of malignant HMECs was altered toward a profile typical of nonmalignant HMECs. Sterin et al. [118] observed increased intracellular GPC in breast cancer cells following treatment with antimicrotubule drugs (paclitaxel, vincristine, colchicine, nocodazole). These data suggest that different molecular interventions can lead to similar end points in choline metabolism.
V. TUMOR pH
The microenvironment of tumors is frequently characterized by an acidic extracellular pH pH and a neutral to alkaline intracellular pH pH . Tumor hypoxia and increased glycolysis causes elevated cellular acid production which, when combined with poor tumor perfusion and efficient mechanisms of proton extrusion, leads to acidic pH in tumors and a neutral to alkaline pH . MRS and MRSI provide a means of detecting both intracellular and extracellular pH. P MR spectra of intact perfused cells, acquired in our MR-compatible perfusion system, showing spectra from (a) MCF-12A human mammary epithelial cells and (b) MDA-MB-231 human breast cancer cells. Breast cancer cells exhibit high PC levels, whereas mammary epithelial cells exhibit low PC and high GPC levels. Following peaks are assigned in the P MR spectra: GPC, glycerophosphocholine; GPE, glycerophosphoethanolamine; NDP, nucleoside diphosphate; NTP, nucleoside triphosphate; PC, phosphocholine; PCr, phosphocreatine; P , inorganic phosphate; PME, phosphomonoesters; PDE, phosphodiesters.
A. P MRS
P MRS can be employed to measure tumor pH using the pH-dependent chemical shift between P and an endogenous reference such as PCr or -NTP [119] . The tumor interstitium and blood plasma have similar P concentrations of 1-2 mM. Therefore, for tumors with an extracellular volume less than 50%, pH as measured by P MRS is weighted toward intracellular pH by at least 70% [120] . This explains why tumor pH measured with P MRS is higher than tumor pH measured with microelectrodes, since the latter method primarily measures extracellular pH [36] . An exogenous compound, 3-aminopropyl phosphonate (3-APP), was employed to determine extracellular tumor pH in vivo using P MRS [121] . Studies in transplanted tumor models demonstrated an acidic extracellular tumor environment and a neutral to alkaline intracellular pH, confirming microelectrode measurements. Gillies et al. [122] demonstrated that below an external pH threshold, Ehrlich ascite cells maintain an intracellular pH value of 7.1 for pH , thereby building up a transmembrane pH gradient. This gradient is energy driven and has been shown to depend on H -ATPases (V-ATPases) that normally reside in acidic organelles but are also located at the cell surface in cancer cells [123] , [124] . In vivo MRS studies revealed that intracellular pH of tumors depended on blood flow and substrate supply [121] , [125] . An acute reduction of blood flow usually resulted in a significant decrease in intracellular pH [125] , [126] .
B. H MRS
While H sensitivity permits pH measurements with a short acquisition time and at higher spatial resolution than P, there are no endogenous markers for measuring pH with H MRS. Therefore, tumor pH measurements using H MRS rely on exogenous extracellular compounds whose spectral resonances are sufficiently separated from those of endogenous metabolites. One such compound is 2-imidazole-1-yl-3-ethoxycarbonylpropionic acid (IEPA), which reported a pH range of 6.4-6.8 in breast cancer xenografts [127] . This range is in agreement with analogous measurements using 3-APP. The advantage of using H MRS is that it provides the ability to obtain colocalized maps of pH with H MRSI of IEPA and of vascular volume and permeability with MRI of albumin-GdDTPA [128] . In addition, these pH maps can be related to metabolite maps of tCho, lactate, N-acetylasparate (NAA), and total creatine (tCr) [129] to understand the relationship between these parameters.
C. CEST
Chemical-exchange dependent saturation transfer (CEST), i.e., the exchange of water protons with those from mobile proteins and peptides, has also been used to measure relative pH in vivo [130] . The pH-dependent amide proton transfer (APT) technique cannot provide absolute pH values since parameters such as the concentration of amide and water protons can affect the measurement. Currently, using this technique, one cannot differentiate between intraand extra-cellular pH.
VI. CONCLUSION
Noninvasive MRI and MRSI provide a wealth of spatial and temporal information on tumor vasculature, metabolism, physiology, receptor and gene expression, and pH. Advances in the development of targeted contrast agents have significantly increased the versatility of MR for molecular imaging and make it an invaluable technique for understanding a complex disease such as cancer. Several of these MR imaging techniques are translatable into the clinic and have the potential to be eventually realized as "bench to bedside" applications.
